Literature DB >> 18176180

Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma.

David T Vistica1, Paula M Krosky, Susan Kenney, Mark Raffeld, Robert H Shoemaker.   

Abstract

Alveolar soft part sarcoma (ASPS), a rare soft tissue sarcoma, is characterized by a chromosomal translocation der(17)t(X;17)(p11;q25) resulting in the production of 2 fusion proteins encoded by regions of the genes for alveolar soft part locus (ASPL) and the transcription factor E3 (TFE3). In this study, polyclonal antibodies were generated to 25 mer peptides encompassing the junctional regions of ASPL-TFE3 type 1 and ASPL-TFE3 type 2. The specificity of the affinity purified antibodies for the synthetic peptides and recombinant expressed ASPL-TFE3 type 1 and ASPL-TFE3 type 2 proteins was evaluated by enzyme-linked immunosorbent assay and was highly fusion type specific. Immunohistochemical staining of formalin-fixed, paraffin-embedded ASPS tumors with the fusion-specific antibodies resulted in intense nuclear staining and differentiation between tumors that express the type 1 protein and tumors that express the type 2 protein. These antibodies will be useful for the differential diagnosis of type 1 and type 2 ASPS and also in the detection of the fusion proteins in biochemical and cell biologic investigations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18176180     DOI: 10.1097/MPH.0b013e31815d1d6f

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  9 in total

1.  Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.

Authors:  Ann Williams; Gillian Bartle; Vaiyapuri P Sumathi; Jeanne M Meis; D Chas Mangham; Rob J Grimer; Lars-Gunnar Kindblom
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

2.  ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcoma.

Authors:  Susan Kenney; David T Vistica; Luke H Stockwin; Sandra Burkett; Melinda G Hollingshead; Suzanne D Borgel; Donna O Butcher; David S Schrump; Robert H Shoemaker
Journal:  J Pediatr Hematol Oncol       Date:  2011-07       Impact factor: 1.289

Review 3.  Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.

Authors:  Lihua Wang; Priya Balasubramanian; Alice P Chen; Shivaani Kummar; Yvonne A Evrard; Robert J Kinders
Journal:  Semin Oncol       Date:  2016-06-15       Impact factor: 4.929

4.  Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.

Authors:  David T Vistica; Melinda Hollingshead; Suzanne D Borgel; Susan Kenney; Luke H Stockwin; Mark Raffeld; David S Schrump; Sandra Burkett; Gary Stone; Donna O Butcher; Robert H Shoemaker
Journal:  J Pediatr Hematol Oncol       Date:  2009-08       Impact factor: 1.289

Review 5.  Primary alveolar soft part sarcoma of vertebra: a case report and literature review.

Authors:  Fei-Peng Zhu; Guang-Ming Lu; Long-Jiang Zhang; Jian-Dong Wang; Xiao-Jing An; Ying-Chun Dong
Journal:  Skeletal Radiol       Date:  2009-04-04       Impact factor: 2.199

6.  Expression of MET in alveolar soft part sarcoma.

Authors:  Hyun Jung Jun; Jeeyun Lee; Do Hyoung Lim; Joon Oh Park; Geunghwan Ahn; Sung Wook Seo; Ki-Sun Sung; Do Hoon Lim; Keon Hee Yoo; Yoon-La Choi
Journal:  Med Oncol       Date:  2009-05-27       Impact factor: 3.064

7.  Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system.

Authors:  Priya Balasubramanian; Robert J Kinders; Shivaani Kummar; Vishal Gupta; David Hasegawa; Anoop Menachery; Scott M Lawrence; Lihua Wang; Katherine Ferry-Galow; Darren Davis; Ralph E Parchment; Joseph E Tomaszewski; James H Doroshow
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

8.  Gene expression profiling of alveolar soft-part sarcoma (ASPS).

Authors:  Luke H Stockwin; David T Vistica; Susan Kenney; David S Schrump; Donna O Butcher; Mark Raffeld; Robert H Shoemaker
Journal:  BMC Cancer       Date:  2009-01-15       Impact factor: 4.430

9.  Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.

Authors:  Anthony P Conley; Van Anh Trinh; Chrystia M Zobniw; Kristi Posey; Jaime D Martinez; Oscar G Arrieta; Wei-Lien Wang; Alexander J Lazar; Neeta Somaiah; Jason Roszik; Shreyaskumar R Patel
Journal:  J Glob Oncol       Date:  2017-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.